Physician

Aziz Bakhous, M.D.

According to 2025 Medicare claims, Aziz Bakhous, M.D. (NPI: 1164787677) practices nephrology in the Sandusky, OH market, with the plurality of this provider's patient population coming from Erie, OH. This provider's primary affiliated billing organization is NORTH COAST PROFESSIONAL COMPANY, LLC (NPI: 1881648210; TIN: 341608091) and primary practice location at 44870-3323. Bakhous is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Bakhous' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 432 traditional Medicare patients, billed 1,768 HCPCS/CPT codes, and received $152,231 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,490 prescription claims across 312 beneficiaries totaling $120,984 in drug costs, led by Sevelamer Carbonate (Sevelamer Carbonate). DME data shows 41 claims. Open Payments data shows 4 records totaling $80. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $15,890 and ending at $152,231. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,349 and ending at $120,984. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	70	244	$15,890
2017	564	1,830	$157,327
2018	632	2,436	$196,917
2019	545	1,902	$164,691
2020	469	1,782	$146,516
2021	472	1,539	$131,561
2022	427	1,799	$134,691
2023	447	1,799	$174,610
2024	432	1,768	$152,231

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	90	$9,349
2016	29	101	$5,548
2017	160	636	$109,107
2018	212	1,074	$134,312
2019	229	1,311	$199,071
2020	201	1,209	$187,720
2021	182	995	$319,121
2022	323	1,029	$168,930
2023	313	1,208	$85,877
2024	312	1,490	$120,984

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$727
2018	N/R	68	$1,436
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$154
2022	N/R	N/R	N/R
2023	N/R	45	$805
2024	N/R	41	$584

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	77	189	$265
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	133	152	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	179	329	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	153	416	$60
90935	Hemodialysis procedure with physician evaluation	51	129	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sevelamer Carbonate	Sevelamer Carbonate	32	1,860	$16,438
Veltassa	Patiromer Calcium Sorbitex	11	369	$12,435
Potassium Chloride	Potassium Chloride	59	4,105	$3,623
Sps	Sodium Polystyrene Sulfon/Sorb	11	160	$3,223
Calcitriol	Calcitriol	180	14,024	$3,074

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$339
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	23	$245

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$80	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aziz Bakhous, M.D.?

Tedicare shows public-source Medicare data for Aziz Bakhous, M.D. (NPI 1164787677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aziz Bakhous, M.D. have ACO affiliation data?

Aziz Bakhous, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Aziz Bakhous, M.D.?

Aziz Bakhous, M.D. is linked to NORTH COAST PROFESSIONAL COMPANY, LLC (billing NPI 1881648210) in the available physician profile data.

Does Aziz Bakhous, M.D. have Open Payments data?

Aziz Bakhous, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.